Medical Journals

The Molecular Basis for Galalpha(1,3)gal Expression in Animals with a Deletion of the Alpha1,3galactosyltransferase Gene.

Authors:
  • Milland Julie
  • Christiansen Dale
  • Lazarus Brooke D
  • Taylor Simon G
  • Xing Pei Xiang
  • Sandrin Mauro S

From: The Austin Research Institute, Austin Health, Heidelberg, Australia.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Feb 2006
  • ISSN: 0022-1767
  • Volume: 176
  • Issue: 4
  • Pages: 2448-54
  • Medium: Print
  • Language: English
  • Citation (JAMA): Milland Julie, Christiansen Dale, Lazarus Brooke D, et al. The Molecular Basis for Galalpha(1,3)gal Expression in Animals with a Deletion of the Alpha1,3galactosyltransferase Gene.. J. Immunol. Feb 2006;176:2448-54

Abstract

The production of homozygous pigs with a disruption in the GGTA1 gene, which encodes alpha1,3galactosyltransferase (alpha1,3GT), represented a critical step toward the clinical reality of xenotransplantation. Unexpectedly, the predicted complete elimination of the immunogenic Galalpha(1,3)Gal carbohydrate epitope was not observed as Galalpha(1,3)Gal staining was still present in tissues from GGTA1(-/-) animals. This shows that, contrary to previous dogma, alpha1,3GT is not the only enzyme able to synthesize Galalpha(1,3)Gal. As iGb3 synthase (iGb3S) is a candidate glycosyltransferase, we cloned iGb3S cDNA from GGTA1(-/-) mouse thymus and confirmed mRNA expression in both mouse and pig tissues. The mouse iGb3S gene exhibits alternative splicing of exons that results in a markedly different cytoplasmic tail compared with the rat gene. Transfection of iGb3S cDNA resulted in high levels of cell surface Galalpha(1,3)Gal synthesized via the isoglobo series pathway, thus demonstrating that mouse iGb3S is an additional enzyme capable of synthesizing the xenoreactive Galalpha(1,3)Gal epitope. Galalpha(1,3)Gal synthesized by iGb3S, in contrast to alpha1,3GT, was resistant to down-regulation by competition with alpha1,2fucosyltransferase. Moreover, Galalpha(1,3)Gal synthesized by iGb3S was immunogenic and elicited Abs in GGTA1 (-/-) mice. Galalpha(1,3)Gal synthesized by iGb3S may affect survival of pig transplants in humans, and deletion of this gene, or modification of its product, warrants consideration.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Base Sequence, Cells, Cultured, Cloning, Molecular, Cricetinae, DNA, Complementary, Disaccharides, Epitopes, Exons, Galactosyltransferases, Gene Deletion, Glycolipids, Humans, Mice, Molecular Sequence Data, RNA, Messenger, Swine


Check for Full Text / PubMed Unique Identifier (PMID): 16456004


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.